During the past decade, Synexus Clinical Research US, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 sponsor was "Allergan" with 2 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Respiratory Syncytial Viruses" (2 trials), "Dyslipidemia" (1 trials) and "Extraintestinal Pathogenic Escherichia Coli Prevention" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (4 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Relamorelin" (2 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "Celecoxib" (1 trials) and "Diclofenac" (1 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research US, Inc." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Synexus Clinical Research US, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".